ANI Pharmaceuticals climbs on annual forecast raise, Q2 results beat

ANI Pharmaceuticals

09/08/2023 16:50

** Shares of drugmaker ANI Pharmaceuticals  ANIP.O  up 8.6%
at $60.76
    ** Company raises 2023 net revenue forecast to $425 mln-$445
mln from $385 mln-$410 mln; above analysts' est. of $406.41 mln
    ** Co also raises annual adj. EPS forecast to $3.62-$4.11
from $2.99-$3.45; also ahead of analysts' expectations of $3.31
    ** ANIP posts Q2 net revenue of $116.5 mln, up 57.8% from a
year earlier; also topping analysts' est. of 98.70 mln
    ** Q2 adj. EPS stood at $1.28 vs $0.13 in Q2 of 2022; ahead
of analysts' est. of $0.68
    ** ANIP shares up 50.09% YTD
    

 (Reporting by Rupali Chaudhary in Bengaluru)
 ((Rupali.chaudhary@thomsonreuters.com))